Skip to main content
. 2015 Sep 22;13:31. doi: 10.1186/s12959-015-0061-1

Table 3.

Levels of the prothrombotic markers according to group characteristics of the population

n D-dimer (ng/mL) F1 + 2 (pmol/L) ETP (nM⋅min)
Sex Male 800 424 (275,755) 238 (175,350) 1576 (1401,1748)
Female 187 609 (399,1008) 287 (203,395) 1494 (1284,1702)
p 0.001 0.001 0.001
Smoking + 474 448 (275,796) 245 (179,347) 1573 (1364,1762)
- 513 467 (295,795) 250 (178,382) 1557 (1368,1726)
p 0.675 0.594 0.269
Previous CVD + 229 484 (286,798) 244 (177,332) 1569 (1348,1733)
- 758 452 (286,796) 247 (180,369) 1563 (1370,1745)
p 0.553 0.386 0.503
HT + 553 553 (355,952) 275 (197,398) 1563 (1366,1730)
- 418 418 (273,773) 235 (174,346) 1565 (1366,1745)
p 0.001 0.001 0.381
Diabetes + 870 454 (246,848) 232 (169,324) 1490 (1261,1754)
- 117 456 (292,795) 249 (180,365) 1572 (1373,1754)
p 0.285 0.142 0.004
LVEF (%) >40 147 440 (285,755) 242 (174,363) 1573 (1371,1735)
≤40 620 679 (408,1156) 297 (189,397) 1488 (1293,1691)
p <0.001 0.016 0.017

Median (25,75 percentiles) values are given

HT hypertension, CVD cardiovascular disease, LVEF left ventricular ejection fraction